MT. LAUREL, N.J., Oct. 11 /PRNewswire-FirstCall/ -- MedQuist Inc. (MEDQ.PK), a leading provider of electronic medical transcription, health information and document management services, today announced that it is in the process of discontinuing support of the AAMT billing unit of measure on its legacy MTS platform. The units of measure on the MTS platform that will continue to be supported by the company are per report pricing and gross line. MedQuist will be sending letters to all of its customers that are serviced on its legacy MTS platform and billed based on the AAMT unit of measure informing them of this decision.
MedQuist is committed to eliminating the use of ratios and formulas as a surrogate for counting the number of “AAMT” transcription lines as quickly as possible and is continuing to evaluate its options for effectuating this on its various platforms. The company expects to make a further announcement about this in the next few weeks.
About MedQuist:
MedQuist is a leading provider of electronic medical transcription, health information and document management services. MedQuist provides document workflow management, digital dictation, speech recognition, mobile dictation devices, Web-based transcription, electronic signature, medical coding products and outsourcing services. MedQuist is a member of the Philips Group of Companies.
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist’s business which are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward- looking statements, see “Risk Factors” in the Company’s Annual Report or Form 10-K for the most recently ended fiscal year.
MedQuist Inc.
CONTACT: MedQuist, +1-800-233-3030
